학회지

권호별 검색

  • HOME
  • 학회지
  • 학회지
  • 권호별 검색
Original Article
Dementia and Neurocognitive Disorders 2010: 9: 2: 41-46

전문보기

알츠하이머병과 기억성 경도인지장애에서 시계 그리기 검사의 양적 분석 및 오류 유형 분석
류선영∙이상봉∙김태우∙송인욱*∙오은영∙최혜영†
가톨릭대학교 대전성모병원 신경과학교실 가톨릭대학교 인천성모병원 신경과학교실* 충남대학교 일반대학원 응용심리학과 임상심리†
Quantitative and Qualitative Analyses of Clock Drawings in Patients with Alzheimer’s Disease and Amnestic Mild Cognitive Impairment
Seon-Young Ryu, M.D., Sang-Bong Lee, M.D., Tae-Woo Kim, M.D., In-Uk Song, M.D.*, Eun-Young Oh, M.S., Hye-Yeoung Choi, B.A.†
Department of Neurology, Daejeon St. Mary’s Hospital, The Catholic University of Korea, Daejeon; Department of Neurology*, Incheon St. Mary’s Hospital, The Catholic University of Korea, Incheon; Clinical Psychology
Background: The Clock Drawing Test (CDT) has been widely used as the neuropsychological instrument to assess the cognitive function in patients with dementia. Amnestic mild cognitive impairment (aMCI) among the subtypes of MCI has a high risk of progression to Alzheimer’s disease (AD). To date, there have been few studies examining the CDT in MCI, in particular compared with AD. The purpose of this study was to compare the performance of CDT in patients with AD and aMCI. Methods: Thirty-four patients with AD and 35 patients with aMCI were participated in this study. The score of CDT was analyzed by three different methods (modified Shulman, Rouleau, and Freedman) and qualitative analyses of CDT were also performed. Results: The results of CDT showed significantly lower performances in the AD group than in the aMCI group according to the three different scoring methods. Qualitative analyses revealed that the ‘conceptual deficit’ error was useful in differentiating between the AD and aMCI groups (p<0.001). Conclusions: The patients with AD had significantly lower performances in CDT than that of the aMCI group. These results suggest that the quantatitive and qualitative analysis of the CDT can help differentiate the patients with AD from the patients with aMCI.
Key Words: Clock drawing test, Alzheimer’s disease, Amnestic mild cognitive impairment